Alnylam Pharmaceuticals, Inc.

HUSSMAN STRATEGIC ADVISORS, INC. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

6,300

Value ($000)

2,505

Weight

0.6%

2025 Q2 - 2025 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	2,505	0.6%	6,300	12/31/2025
2025 Q2	8/5/2025	2,054	0.5%	6,300	6/30/2025